1. Home
  2. RVPH vs HSON Comparison

RVPH vs HSON Comparison

Compare RVPH & HSON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • HSON
  • Stock Information
  • Founded
  • RVPH 2006
  • HSON 1999
  • Country
  • RVPH United States
  • HSON United States
  • Employees
  • RVPH N/A
  • HSON N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • HSON Professional Services
  • Sector
  • RVPH Health Care
  • HSON Consumer Discretionary
  • Exchange
  • RVPH Nasdaq
  • HSON Nasdaq
  • Market Cap
  • RVPH 32.8M
  • HSON 26.1M
  • IPO Year
  • RVPH N/A
  • HSON N/A
  • Fundamental
  • Price
  • RVPH $0.40
  • HSON $8.72
  • Analyst Decision
  • RVPH Strong Buy
  • HSON
  • Analyst Count
  • RVPH 5
  • HSON 0
  • Target Price
  • RVPH $9.00
  • HSON N/A
  • AVG Volume (30 Days)
  • RVPH 3.4M
  • HSON 14.9K
  • Earning Date
  • RVPH 08-13-2025
  • HSON 08-07-2025
  • Dividend Yield
  • RVPH N/A
  • HSON N/A
  • EPS Growth
  • RVPH N/A
  • HSON N/A
  • EPS
  • RVPH N/A
  • HSON N/A
  • Revenue
  • RVPH N/A
  • HSON $138,031,000.00
  • Revenue This Year
  • RVPH N/A
  • HSON $0.80
  • Revenue Next Year
  • RVPH N/A
  • HSON $8.09
  • P/E Ratio
  • RVPH N/A
  • HSON N/A
  • Revenue Growth
  • RVPH N/A
  • HSON N/A
  • 52 Week Low
  • RVPH $0.30
  • HSON $8.28
  • 52 Week High
  • RVPH $4.28
  • HSON $18.99
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 33.44
  • HSON 42.64
  • Support Level
  • RVPH $0.35
  • HSON $8.35
  • Resistance Level
  • RVPH $0.83
  • HSON $8.80
  • Average True Range (ATR)
  • RVPH 0.06
  • HSON 0.33
  • MACD
  • RVPH -0.01
  • HSON 0.05
  • Stochastic Oscillator
  • RVPH 17.36
  • HSON 27.69

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About HSON Hudson Global Inc.

Hudson Global Inc provides specialized recruitment and related talent solutions. Its core services include Permanent recruitment, Contracting, Recruitment process outsourcing (RPO) and Talent management solutions. Its Permanent recruitment services leverage the company's consultants. In contracting services, it offers project management, interim management and professional contract staffing services. RPO services deliver permanent and contracting outsourced recruitment solutions to various companies whereas, Talent management solutions feature services like talent assessment, interview training, executive coaching, employee development and outplacement.

Share on Social Networks: